3-Isobutylglutaric acid

We are 3-Isobutylglutaric acid CAS:75143-89-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-Isobutylglutaric acid
CAS.NO:75143-89-4
Synonyms:
3-(2-methylpropyl)pentanedioic acid

Molecular Formula: C9H16O4
Molecular Weight: 188.22100

Physical and Chemical Properties:
Density: 1.126 g/cm3
Boiling point: 326.197ºC at 760 mmHg
Melting point: /
Flash point: 165.289ºC
Refractive index: 1.472

Specification:
Appearance: White to pale brown  powder
Purity:≥99%
Moisture Content: ≤0.1%
Impurity: ≤0.5%
Residue on Ignition: 0.1%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Pregabalin CAS:148553-50-8

Related News: This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?2'-deoxyadenosine CAS:958-09-8 China has a complete upstream and downstream industry chain, lower costs, and good talent reserves. It is one of the few industries in China that has an advantage in international competition.Sulfuryl dichloride Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday’s guideline said.2-imidazo[1,2-a]pyridin-3-ylacetic acid The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently.